Two Sigma Advisers’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Sell |
1,033,400
-1,553,200
| -60% | -$28.3M | 0.04% | 352 |
|
|
2025
Q1 | $51.3M | Sell |
2,586,600
-363,524
| -12% | -$7.21M | 0.12% | 181 |
|
|
2024
Q4 | $50.6M | Sell |
2,950,124
-1,504,276
| -34% | -$25.8M | 0.12% | 165 |
|
|
2024
Q3 | $89M | Sell |
4,454,400
-200,200
| -4% | -$4M | 0.21% | 95 |
|
|
2024
Q2 | $52M | Buy |
4,654,600
+1,195,000
| +35% | +$13.4M | 0.12% | 165 |
|
|
2024
Q1 | $22.8M | Buy |
3,459,600
+682,000
| +25% | +$4.5M | 0.05% | 313 |
|
|
2023
Q4 | $12.6M | Sell |
2,777,600
-388,500
| -12% | -$1.76M | 0.03% | 449 |
|
|
2023
Q3 | $11.3M | Buy |
3,166,100
+406,200
| +15% | +$1.45M | 0.03% | 435 |
|
|
2023
Q2 | $10.2M | Buy |
2,759,900
+751,300
| +37% | +$2.77M | 0.03% | 476 |
|
|
2023
Q1 | $6.65M | Buy |
2,008,600
+1,446,400
| +257% | +$4.79M | 0.02% | 693 |
|
|
2022
Q4 | $2.18M | Buy |
562,200
+535,500
| +2,006% | +$2.08M | 0.01% | 1194 |
|
|
2022
Q3 | $65K | Buy |
+26,700
| New | +$65K | ﹤0.01% | 2355 |
|
|
2020
Q1 | – | Sell |
-11,000
| Closed | -$44K | – | 2444 |
|
|
2019
Q4 | $44K | Buy |
+11,000
| New | +$44K | ﹤0.01% | 2295 |
|